Predictors of Node Positivity in Endometrial Cancer

Recruiting now

Conditions studied: Endometrial Cancer

In brief

To investigate the role of histological and moleculr profile of endometrial cancer patietns in predicting the risk of nodal metastases in endometrila cancer patients.

Key facts

Study ID

NCT05793333

Run by

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

People needed

200

Starts

2022-01-10

Expected to finish

2025-01-01

Last updated by the study team

2024-09-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Written informed consent
• Histologically confirmed endometrila cancer
• Data on molecular genomic profiling (POLE mutated, p53 abnormalities, MMRd/MSI-H, and NSMP)
• Data on histological characteristics of the ttumor
• Execution of sentinel node mapping
• Data on sentinel node status (negative vs. positive)

You may not qualify if…

• Stage IVB endoemtrial cancer
• consent withdraw

Where it is running

• Fondazione IRCCS Istituto Nazionale dei Tumori — Milan, Lombardy, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.